| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 149, 575-583, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
Y Nakamura, R Iwamoto and E Mekada
Department of Pathology, St. Mary's Hospital, Kurume University, Japan.
CD9 is a member of the newly identified tetra-membrane-spanning protein family. We show here that CD9 is a constituent of myelin in the central and peripheral nervous systems. Expression of CD9 was detected in human cerebral white matter and sciatic nerve by Northern and Western blotting. Myelin in the central and peripheral nervous systems was strongly stained with a monoclonal antibody against human CD9 antigen in paraffin-embedded sections. CD9 was detected in adult nervous tissue but not in developing brain at less than 20 weeks of gestation. Immunohistochemical studies indicated that expression of CD9 is correlated with myelination and is somewhat delayed compared with expression of myelin basic protein, a major component protein of myelin. In the central nervous system, CD9 was detected along the outermost membrane of compact myelin but not inside compact myelin or the periaxonal region. Although the membrane-anchored form of heparin- binding epidermal-growth-factor-like growth factor (proHB-EGF), which is identical to the diphtheria toxin receptor, forms a complex with CD9 in some human and monkey cell lines, proHB-EGF was not detected in myelin immunocytochemically. The distribution of CD9 in the outer surface of myelin and its relatively late developmental appearance suggest that CD9 may interact with the extracellular matrix or cell adhesion molecules and participate in the maintenance of the entire myelin sheath.
This article has been cited by other articles:
![]() |
J.-C. Wang, L. R. Begin, N. G. Berube, S. Chevalier, A. G. Aprikian, H. Gourdeau, and M. Chevrette Down-Regulation of CD9 Expression during Prostate Carcinoma Progression Is Associated with CD9 mRNA Modifications Clin. Cancer Res., April 15, 2007; 13(8): 2354 - 2361. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ishibashi, L. Ding, K. Ikenaka, Y. Inoue, K. Miyado, E. Mekada, and H. Baba Tetraspanin Protein CD9 Is a Novel Paranodal Component Regulating Paranodal Junctional Formation J. Neurosci., January 7, 2004; 24(1): 96 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kawashima, K. Doh-ura, E. Mekada, M. Fukui, and T. Iwaki CD9 Expression in Solid Non-neuroepithelial Tumors and Infiltrative Astrocytic Tumors J. Histochem. Cytochem., September 1, 2002; 50(9): 1195 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-J. Won and J. F. Kearney CD9 Is a Unique Marker for Marginal Zone B Cells, B1 Cells, and Plasma Cells in Mice J. Immunol., June 1, 2002; 168(11): 5605 - 5611. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakamura, K. Handa, R. Iwamoto, T. Tsukamoto, M. Takahasi, and E. Mekada Immunohistochemical Distribution of CD9, Heparin Binding Epidermal Growth Factor-like Growth Factor, and Integrin {{alpha}}3{beta}1 in Normal Human Tissues J. Histochem. Cytochem., April 1, 2001; 49(4): 439 - 444. [Abstract] [Full Text] |
||||
![]() |
K. Miyado, G. Yamada, S. Yamada, H. Hasuwa, Y. Nakamura, F. Ryu, K. Suzuki, K. Kosai, K. Inoue, A. Ogura, et al. Requirement of CD9 on the Egg Plasma Membrane for Fertilization Science, January 14, 2000; 287(5451): 321 - 324. [Abstract] [Full Text] |
||||
![]() |
M. Frank, M. E. van der Haar, N. Schaeren-Wiemers, and M. E. Schwab rMAL Is a Glycosphingolipid-Associated Protein of Myelin and Apical Membranes of Epithelial Cells in Kidney and Stomach J. Neurosci., July 1, 1998; 18(13): 4901 - 4913. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakamura, T. Mitamura, T. Takahashi, T. Kobayashi, and E. Mekada Importance of the Major Extracellular Domain of CD9 and the Epidermal Growth Factor (EGF)-like Domain of Heparin-binding EGF-like Growth Factor for Up-regulation of Binding and Activity J. Biol. Chem., June 9, 2000; 275(24): 18284 - 18290. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |